Is Alzheimer's disease a mitochondrial disorder?

被引:31
|
作者
Cash, AD [1 ]
Perry, G [1 ]
Ogawa, O [1 ]
Raina, AK [1 ]
Zhu, XW [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
Alzheimer's disease; amyloid-beta; antioxidants; free radicals; mitochondria; neurodegeneration;
D O I
10.1177/107385802236968
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cell bodies of neurons at risk of death in Alzheimer's disease (AD) have increased lipid peroxidation, nitration, free carbonyls, and nucleic acid oxidation. These oxidative changes occur in all vulnerable neurons and are reduced in neurons that contain neurofibrillary pathology. In this review, the authors provide a summary of recent work that demonstrates key abnormalities that may play a part in initiating and promoting neuronal oxidative damage. Mitochondrial abnormalities are clearly involved as a source of reactive oxygen species that culminates in perikaryal oxidative damage. However, because mitochondria in AD do not exhibit striking evidence of oxidative damage, as would be expected if they produced free radicals directly, the authors suspected that abnormal mitochondria are responsible for supplying a key reactant, that once in the cytoplasm, releases radicals. Because abnormal mitochondria, H2O2 and redox-active iron are juxtaposed in the same AD neuron, it has all the markings of a "radical factory." The proximal causes of mitochondrial abnormalities likely involve reentry into the cell cycle, where organellokinesis and proliferation results in an increase of mitochondria and intermediately differentiated cells, with a consequent increase in turnover. Supporting this, the authors have considerable in vivo and in vitro evidence for mitotic disturbances in AD.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [31] Mitochondrial therapeutic interventions in Alzheimer's disease
    Giau, Vo Van
    An, Seong Soo A.
    Hulme, John P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 395 : 62 - 70
  • [32] Mitochondria and Mitochondrial Cascades in Alzheimer's Disease
    Swerdlow, Russell H.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1403 - 1416
  • [33] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [34] Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
    Chris Cadonic
    Mohammad Golam Sabbir
    Benedict C. Albensi
    Molecular Neurobiology, 2016, 53 : 6078 - 6090
  • [35] Metabolomics and mitochondrial dysfunction in Alzheimer’s disease
    Dong Hee Kim
    Jeong-An Gim
    Dahye Yoon
    Suhkmann Kim
    Heui-Soo Kim
    Genes & Genomics, 2017, 39 : 295 - 300
  • [36] Role of mitochondrial dysfunction in Alzheimer's disease
    Castellani, R
    Hirai, K
    Aliev, G
    Drew, KL
    Nunomura, A
    Takeda, A
    Cash, AD
    Obrenovich, ME
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 357 - 360
  • [37] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03) : 407 - 410
  • [38] Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease
    Sayehmiri, Fatemeh
    Motamedi, Fereshteh
    Batool, Zehra
    Naderi, Nima
    Shaerzadeh, Fatima
    Zoghi, Anahita
    Rezaei, Omidvar
    Khodagholi, Fariba
    Pourbadie, Hamid Gholami
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (08)
  • [39] Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease
    Reddy, P. Hemachandra
    EXPERIMENTAL NEUROLOGY, 2009, 218 (02) : 286 - 292
  • [40] ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis
    Ebanks, Brad
    Ingram, Thomas L.
    Chakrabarti, Lisa
    AGING-US, 2020, 12 (16): : 16647 - 16662